Cue Biopharma Inc
NASDAQ:CUE

Watchlist Manager
Cue Biopharma Inc Logo
Cue Biopharma Inc
NASDAQ:CUE
Watchlist
Price: 0.48705 USD -7.81%
Market Cap: 38.4m USD

Wall Street
Price Targets

CUE Price Targets Summary
Cue Biopharma Inc

Wall Street analysts forecast CUE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CUE is 4.08 USD with a low forecast of 2.02 USD and a high forecast of 6.3 USD.

Lowest
Price Target
2.02 USD
315% Upside
Average
Price Target
4.08 USD
738% Upside
Highest
Price Target
6.3 USD
1 194% Upside
Cue Biopharma Inc Competitors:
Price Targets
VCYT
Veracyte Inc
13% Upside
CRVO
Diffusion Pharmaceuticals Inc
160% Upside
ARQT
Arcutis Biotherapeutics Inc
9% Upside
CCCC
C4 Therapeutics Inc
376% Upside
6855
Ascentage Pharma Group International
78% Upside
300685
Amoy Diagnostics Co Ltd
34% Upside
688235
Beigene Ltd
33% Upside

Revenue
Forecast

Revenue Estimate
Cue Biopharma Inc

The compound annual growth rate of Cue Biopharma Inc's revenue for the next 3 years is 31%.

N/A
Past Growth
31%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Cue Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Cue Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CUE's stock price target?
Price Target
4.08 USD

According to Wall Street analysts, the average 1-year price target for CUE is 4.08 USD with a low forecast of 2.02 USD and a high forecast of 6.3 USD.

What is Cue Biopharma Inc's Revenue forecast?
Projected CAGR
31%

The compound annual growth rate of Cue Biopharma Inc's revenue for the next 3 years is 31%.

Back to Top